Early research (Phase 1)Active Not RecruitingNCT04485013What this trial is testingTTX-080 HLA-G Antagonist in Subjects With Advanced CancersWho this might be right forCancer Tizona Therapeutics, Inc 240
Testing effectiveness (Phase 2)Looking for participantsNCT06265025What this trial is testingGM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid TumorsWho this might be right forHead and Neck CancerMalignant MelanomaColorectal Cancer+3 more GeneMedicine Co., Ltd. 125
Early research (Phase 1)Looking for participantsNCT04777994What this trial is testingStudy With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic TumorsWho this might be right forAdvanced Solid Tumor Cancer Calico Life Sciences LLC 248
Early research (Phase 1)Study completedNCT01625351What this trial is testingCD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and LymphomasWho this might be right forEwing SarcomaGastrointestinal TumorGerm Cell Tumor+10 more St. Jude Children's Research Hospital 23
Testing effectiveness (Phase 2)UnknownNCT02886897What this trial is testingCombinations of D-CIK Immunotherapy And Anti-PD-1 In Refractory Solid TumorsWho this might be right forHepatocellular CarcinomaRenal Cell CarcinomaBladder Cancer+3 more Sun Yat-sen University 50
Early research (Phase 1)Study completedNCT01391143What this trial is testingSafety Study of MGA271 in Refractory CancerWho this might be right forProstate CancerMelanomaRenal Cell Carcinoma+4 more MacroGenics 179
Early research (Phase 1)Study completedNCT02835833What this trial is testingStudy of Nintedanib Plus Bevacizumab in Advanced Solid TumorsWho this might be right forRenal Cell CarcinomaColorectal AdenocarcinomaNon-squamous Non-small Cell Lung Cancer+2 more University of Alabama at Birmingham 21
Testing effectiveness (Phase 2)Ended earlyNCT00651482What this trial is testingTreatment of Refractory Metastatic Renal Cell Carcinoma With Bevacizumab and RAD001 (Everolimus)Who this might be right forKidney NeoplasmsKidney (Renal Cell) Cancer Sandy Srinivas 10
Testing effectiveness (Phase 2)Study completedNCT00089648What this trial is testingSU011248 In The Treatment Of Patients With Bevacizumab (Avastin)-Refractory Metastatic Renal Cell CarcinomaWho this might be right forCarcinoma, Renal Cell Pfizer 61
Early research (Phase 1)Ended earlyNCT00492440What this trial is testingInterleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney CancerWho this might be right forKidney CancerMelanoma (Skin) Cytheris SA 9
Testing effectiveness (Phase 2)WithdrawnNCT00556205What this trial is testingBevacizumab With or Without Sunitinib in Sunitinib-Refractory Renal Cell CarcinomaWho this might be right forRenal Cell Carcinoma Massachusetts General Hospital
Early research (Phase 1)Looking for participantsNCT07072234What this trial is testingPhase I Study of Allogeneic Transforming Growth Factor-beta Receptor Type 2 Knockout CD70 CAR NK Cells in Treatment Refractory Clear Cell Renal Cell CarcinomaWho this might be right forClear Cell CarcinomaPhase 1Growth Factor M.D. Anderson Cancer Center 30
Early research (Phase 1)Looking for participantsNCT06910657What this trial is testingIDOV-Immune for Advanced Solid TumorsWho this might be right forColorectal CancerPancreatic CancerMelanoma+13 more ViroMissile, Inc. 78
Testing effectiveness (Phase 2)Ended earlyNCT00788125What this trial is testingDasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid TumorsWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+8 more City of Hope Medical Center 7
Testing effectiveness (Phase 2)Study completedNCT00866320What this trial is testingSorafenib in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Sunitinib or BevacizumabWho this might be right forKidney Cancer Case Comprehensive Cancer Center 49
Early research (Phase 1)Study completedNCT02071862What this trial is testingStudy of the Glutaminase Inhibitor CB-839 in Solid TumorsWho this might be right forSolid TumorsTriple-Negative Breast CancerNon Small Cell Lung Cancer+7 more Calithera Biosciences, Inc 210
Not applicableWithdrawnNCT00499291What this trial is testingPaclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid TumorsWho this might be right forCancer Eastern Cooperative Oncology Group
Early research (Phase 1)Active Not RecruitingNCT04514484What this trial is testingTesting the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIVWho this might be right forAdvanced Differentiated Thyroid Gland CarcinomaAdvanced Head and Neck CarcinomaAdvanced Hepatocellular Carcinoma+60 more National Cancer Institute (NCI) 8
Early research (Phase 1)Not Yet RecruitingNCT07686744What this trial is testingNeoantigen Peptide Vaccine Plus Pembrolizumab in Renal Cell CarcinomaWho this might be right forRenal Cell CarcinomaAdvancedRecurrent+1 more Jian Lin 8
Early research (Phase 1)Study completedNCT00161187What this trial is testingIrradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid TumorWho this might be right forCancer University of Medicine and Dentistry of New Jersey 37